Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Slow-Release "Jelly" Novel Drug Deliverer

Published: Wednesday, January 30, 2013
Last Updated: Wednesday, January 30, 2013
Bookmark and Share
Biomedical engineers have developed a novel method to overcome the major hurdles facing a promising new class of peptide drugs to treat diseases such as diabetes and cancer.

For example, the hormone insulin is a peptide, which regulates the metabolism of carbohydrates in the body and is used as a drug to treat diabetes. There are more than 40 peptide drugs approved for use in humans and more than 650 are being tested in clinical studies.

However, despite their effectiveness, these peptide drugs cannot achieve their full potential for a number of reasons. First, they are rapidly degraded in the blood stream. A second major drawback is their rapid clearance from the body, which requires multiple, frequent injections. Because of this, their concentrations in the blood can rise precipitously right after injection and fall dramatically soon thereafter, causing unwanted side effects for patients.

One popular method to solve this problem involves loading peptide drugs into polymer microspheres that are injected under the skin and slowly degrade and release the peptide drug.   Microsphere-release technology has proven useful, but has many issues related to its manufacture and ease of patient use, the researchers said.

“We wanted to know if we could create a system that does what the polymer microspheres do, but gets rid of the microspheres and is more patient friendly,” said Ashutosh Chilkoti, Theo Pilkington Professor of Biomedical Engineering at Duke’s Pratt School of Engineering.

The new approach involves making a “fusion protein” that consists of multiple copies of a peptide drug fused to a polymer that makes the fusion protein sensitive to body heat. The fusion molecule is a liquid in a syringe but transforms into a “jelly” when injected under the skin.  Enzymes in the skin attack the depot and liberate copies of the peptide, which provides a constant and controllable release of drug over time.

Miriam Amiram, former Chilkoti graduate student and first author on the paper, dubbed the new delivery system POD, for protease-operated depot.

In the latest experiments, published on-line in the journal Proceedings of the National Academy of Science, the researchers fused glucagon-like peptide-1 (GLP-1), a hormone that regulates the release of insulin, with a genetically engineered heat sensitive polymer to create the POD.

“Remarkably, a single injection of the GLP-1 POD was able to reduce blood glucose levels in mice for up to five days, which is 120 times longer than an injection of the peptide alone,” Chilkoti said.  “For a patient with type 2 diabetes, it would be much more desirable to inject such a drug once a week or once a month rather than once or twice a day.

“Additionally, this approach avoids the peaks and valleys of drug concentrations that these patients often experience,” Chilkoti said.

Unlike peptide-loaded microspheres, PODs are also easy to manufacture, as the peptide drug and the heat-sensitive polymer are all made of amino acids, so that they are expressed as one long stretch of amino acids in bacteria.

“Our experiments demonstrate that this new delivery system provides the first entirely genetically encoded alternative to existing peptide drug encapsulation approaches for sustained delivery of peptide drugs,” Chilkoti said.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Breast Cancer Cells Starve for Cystine
Depriving triple negative breast cancer, a treatment-resistant form of breast cancer, of cystine results in cancer cell death.
Wednesday, November 23, 2016
Key Protein for Spinal Cord Repair Identified
Researchers have identifed healing proteins that bridge severed spinal tissue in zebrafish, leading to spinal repair.
Monday, November 07, 2016
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Wednesday, October 19, 2016
Converting Isolated Cells with Gene Editing
Researchers have used CRISPR to generate neuronal cells from isolated connective tissue.
Tuesday, August 23, 2016
Directly Reprogramming a Cell's Identity with Gene Editing
Duke engineers use CRISPR to generate neuronal cells from connective tissue.
Friday, August 12, 2016
New ‘Mega-Complex’ Involved in Cell Signaling Discovered
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
Tuesday, August 09, 2016
Disentangling the Plant Microbiome
Study says breeding plants, to feed a growing global population, with more beneficial bacteria is far from simple.
Thursday, July 14, 2016
Poverty Marks a Gene, Predicting Depression
New study of high-risk teens reveals a biological pathway for depression.
Thursday, May 26, 2016
Poliovirus Therapy Wins 'Breakthrough' Status
FDA decision will fast-track research on breakthrough Duke brain cancer therapy.
Wednesday, May 18, 2016
Enzyme Structure May Aid Antibiotic Development
Targeted enzyme is essential to every known strain of bacteria.
Wednesday, April 20, 2016
Coding and Computers Help Spot Methane, Explosives
Coded apertures improve and shrink mass spectrometers for field use.
Tuesday, April 19, 2016
Why Bearcats Smell Like Buttered Popcorn
Researchers pinpoint chemical compound that gives rare animal its popcorn-like scent.
Friday, April 15, 2016
Antibiotics Don't Promote Swapping of Resistance Genes
Bacterial resistance spreads through population dynamics, not an increase in gene transfers.
Wednesday, April 13, 2016
Genetic Elements that Drive Regeneration
Limb or organ regrowth may be hidden in our genes.
Friday, April 08, 2016
Immunity Genes Could Protect Some From E. Coli
When a child comes home from preschool with a stomach bug that threatens to sideline the whole family for days, why do some members of the family get sick while others are unscathed?
Monday, January 25, 2016
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Transporting Microscopic Cargo Between Human Cells
Scientists have developed a virus-inspired delivery system for material transport between cells.
Tissue Damage Is Key for Cell Reprogramming
Researchers have shown tissue damage is important for cells to return to an embryonic state for cell reprogramming.
Metabolite Promotes Cancer Cell Transformation
Researchers have identified a metabolite that promotes cancer cell transformation and colorectal cancer spread.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Bird Flu Confirmed in the Netherlands
An outbreak of H5 avian influenza was confirmed in the Flevoland province of the Netherlands.
Pasteurised Bacterium Reduces Obesity and Diabetes
Researchers have discovered that an intestinal bacterium provides a lasting effect on the intestinal barrier.
Turning Off Asthma Attacks
Researchers discover a critical cellular “off” switch for the inflammatory immune response that causes asthma attacks.
Scroll Up
Scroll Down

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!